Recent investment activity

KANDO id: 106781

Corporate information

Registration country

Funding rounds

Acquisition USD 20,000,000,000


USD 20,000,000,000 ( ) at USD 20,000,000,000 pre-money valuation

Profile Country Notes
Sanofi Aventis USD 20,000,000,000 (USD 20,000,000,000) Initial investment.

Profile Country
Kleiner Perkins Caufield & Byers LLC (KPCB) Venture capital firm.

Actual initial investment stage

Investment activity status
Active investor

Selected investments

Displaying 1 - 5 of 5
Profile Country Date Funding
Bluebird Bio Inc Developer of an innovative gene therapies for severe genetic disorders Series B
GelTex Pharmaceuticals Acquisition 1,000,000,000 (USD 1,000,000,000)
ILEX Oncology Inc N/A
Sirtris Pharmaceuticals Inc Series C
Fate Therapeutics Inc Series B Initial investment

Current team

Past employees

Selected Products / Customers

Financials